MARKET

PLUR

PLUR

Pluri Inc
NASDAQ
1.820
-0.020
-1.09%
Opening 10:10 08/11 EDT
OPEN
1.820
PREV CLOSE
1.840
HIGH
1.820
LOW
1.808
VOLUME
1.81K
TURNOVER
--
52 WEEK HIGH
5.68
52 WEEK LOW
1.450
MARKET CAP
19.64M
P/E (TTM)
-0.6306
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PLUR last week (0803-0807)?
Weekly Report · 1d ago
Weekly Report: what happened at PLUR last week (0727-0731)?
Weekly Report · 08/03 09:06
Pluri Unit Cellav Health And Aesthetics Completes Cosmetic Regulatory Registration And Notification In The UK, Supporting Commercial Launch Of Regenativo+
Benzinga · 07/28 12:06
Weekly Report: what happened at PLUR last week (0720-0724)?
Weekly Report · 07/27 09:06
Weekly Report: what happened at PLUR last week (0713-0717)?
Weekly Report · 07/20 09:06
Pluri in ongoing talks to extend EIB financing
TipRanks · 07/15 07:53
Pluri chairman raises stake above 30%; shares up
Seeking Alpha · 07/14 13:22
Pluri announces chairman Alejandro Weinstein ownership surpasses 30%
TipRanks · 07/14 11:20
More
About PLUR
Pluri Inc., formerly known as Pluristem Therapeutics Inc., is an Israel-headquartered company engaged in the research and provision of cell-based products directed for a range of industries. The Company is focused on researching and developing cell transformation and 3D cell expansion technologies that allow mass production of cells. The products of the Company are used for the pharmaceutical industry as well as for food technology, agriculture technology, and cell-based materials. In the pharmaceutical sector, the Company's preclinical and clinical programs explore multiple therapeutic areas such as vascular disease, inflammation-related conditions, muscle injuries, and hematological disorders. In the food sector, the Firm produces cultivated meat, cultivated fish, and seafood, as well as plant-based products. In agriculture, the Company develops alternative farming methods. The Company has a portfolio of over 140 granted patents in approximately 52 countries.

Webull offers Pluri Inc stock information, including NASDAQ: PLUR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLUR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLUR stock methods without spending real money on the virtual paper trading platform.